The Congress finds the following:
(1)
The Institute of Medicine of the National Academies advises the United States Government on nutritional science for use in the formation of public policy, including product labeling programs.
(2)
In 2002, the Institute of Medicine—
(A)
issued recommended dietary reference intake amounts for energy, carbohydrates, fiber, fat, fatty acids, cholesterol, protein, and amino acids; and
(B)
made recommendations regarding consumption of trans fat.
(3)
These recommendations included the following statement: “trans fatty acids are not essential and provide no known benefit to human health”.
(4)
The Institute of Medicine concluded that—
(A)
both saturated and trans fats increase levels of LDL cholesterol; and
(B)
trans fats may also lower levels of HDL cholesterol.
(5)
A 2006 New England Journal of Medicine scientific review stated that “from a nutritional standpoint, the consumption of trans fatty acids results in considerable potential harm but no apparent benefit”.
(6)
Based on this overwhelming scientific evidence, in 2013, the Food and Drug Administration issued a preliminary determination that partially hydrogenated oils, which are the primary dietary source of artificial trans fats, are not “generally recognized as safe” for use as an ingredient in food.
(7)
Notwithstanding such preliminary determination, certain foods will still contain a certain level of naturally-occurring trans fats, and current laws and regulations, which only require that the labeling of food containing a certain threshold amount of trans fats bear that fact, will remain in effect.